Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) announced this afternoon that its shareholders approved its combination with drug developer Carmell at a special meeting held on July 11.
At yesterday’s meeting, a total of at least 15,511,079 shares, or 78.46%, of ALPA’s issued and outstanding common stock were present either in person or by proxy, which constituted a quorum.
Redemption figures and a closing timeline have not been disclosed by the parties, but the deal received support from investors holding a total of 12,006,101 shares that voted in favor of it.
Earlier this week, Alpha Healthcare III signed a forward purchase agreement (FPA) and a non-redemption agreement to support its combination with Carmell. As part of the agreement, Meteora Special Opportunity Fund I will purchase an amount of shares equal to 9.5% of ordinary Alpha Healthcare III stock at close. It will be prepaid for these purchases at its redemption price out of funds from the SPAC’s trust.
Additionally, Meteora agreed to not redeem 100,000 other shares that it currently holds.
Alpha Healthcare III initially inked the $188 million merger with Carmell in January. Pittsburgh-based Carmell is developing a treatment platform to accelerate healing in bone fractures and soft tissue wounds.
The combined company is expected to trade on the Nasdaq under the symbol “CTCX” once the deal is completed.
StoneBridge II (NASDAQ:APACU) has filed for a $50 million SPAC underwritten by Maxim Group to hunt down a non-US target with a particular eye on India. The new SPAC is coming to market with one right to a 1/10 share in each unit and its trust will not be overfunded. Maxim has now underwritten two...
At the SPAC of Dawn Three new SPACs have gotten in line for IPOs even as the market’s rally appears set to soften in today’s trading. Many eyes will be on the reading of the US’ March trade deficit for signs where the country’s trade policy might shift next. But, policy shifts have also unlocked...
At the SPAC of Dawn Last week’s hot streak continues this week in the form of a high volume of votes for SPACs. Two are seeking approvals for their business combinations while six more aim to get the stamp on their extension votes. Investors will also have an eye on upcoming Fed comments on Wednesday...
Terms Tracker for the Week Ending May 2, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. April wrapped with some real momentum. Over the course of the month, 19 SPACs filed new S-1s, while 12 IPOs priced. Furthermore, nine deal announcements...
ProCap Acquisition Corp. (NASDAQ:PCAPU) has filed for a $200 million SPAC to hunt for a fintech or financial services target. The new S-1 filing was BTIG’s second of the week after a two-month break, bringing its 2025 new SPAC filings to five and the bank has so far managed to IPO five SPACs as well....